While the COVID-19 pandemic will have a negative impact on the Latin American peripheral vascular device market in the short term, a large undiagnosed patient population, rising PVD diagnosis rates…
While the COVID-19 pandemic has had a negative impact on the European peripheral vascular device market in the short term, the dynamic nature of the PV market, the launch of novel premium-price…
While the COVID-19 pandemic will have a negative impact on the Asia Pacific peripheral vascular device market in the short term, the market will grow modestly through 2030, fueled by the growing…
While the COVID-19 pandemic will have a negative impact on the Asia Pacific peripheral vascular device market in the short term, the market will grow modestly through 2030, fueled by the growing…
The European market for PV devices is a dynamic market that will grow steadily through 2029, driven by the availability of new products backed by clinical data. However, market revenues will be…
A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost…
The continuing emergence of data supporting the safety of paclitaxel-coated devices will drive growing adoption of premium-priced DES and DCBs, supporting modest growth overall in the Japanese PV…
The European market for PV devices is a dynamic market that will grow steadily through 2029, driven by the availability of new products backed by clinical data. However, market revenues will…
The Canadian market for PV devices is an evolving market in which an underdiagnosed and underserved patient population and innovative product launches will facilitate significant procedure…